Biotech / Pharma
EMC2 Bio
Biotech / Pharma
EMC2 Bio, a Johns Hopkins-affiliated biotech, develops an antibody-nanoparticle conjugate to deliver genetic cargo to pancreatic beta cells, protecting them from immune destruction in Type 1 diabetes.
Founded
Region
Investors
People